Pemetrexed is an antifolate metabolite that inhibits several enzymes involved in the folate pathway. It has activity against various solid tumours, and has been approved for treatment of malignant pleural mesothelioma on the basis of findings from a randomised phase III trial.1 The main toxic effects noted for pemetrexed have been rash, myelosuppression, diarrhoea, mucositis, and reversible elevation of liver enzymes—effects that are preventable partly by vitamin supplementation.1

Severe rhabdomyolysis associated with pemetrexed-based chemotherapy

Milella, M;
2006-01-01

Abstract

Pemetrexed is an antifolate metabolite that inhibits several enzymes involved in the folate pathway. It has activity against various solid tumours, and has been approved for treatment of malignant pleural mesothelioma on the basis of findings from a randomised phase III trial.1 The main toxic effects noted for pemetrexed have been rash, myelosuppression, diarrhoea, mucositis, and reversible elevation of liver enzymes—effects that are preventable partly by vitamin supplementation.1
permetrexed
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1470204506706623-main.pdf

accesso aperto

Licenza: Dominio pubblico
Dimensione 42.94 kB
Formato Adobe PDF
42.94 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/1064846
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? 13
social impact